American Journal of Cardiovascular Drugs

期刊简介：Promoting rational therapy within the discipline of cardiology, the American Journal of Cardiovascular Drugs covers all aspects of the treatment of cardiovascular disorders, particularly the place in therapy of newer and established agents.Via a program of reviews and original clinical research articles, the journal addresses major issues relating to treatment of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of cardiovascular disorders; and the practical management of specific clinical situations.The American Journal of Cardiovascular Drugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

【译文】在心脏病学领域推广合理治疗，美国心血管药物杂志涵盖了心血管疾病治疗的所有方面，特别是新药和已建立药物在治疗中的地位。通过综述和原创临床研究文章，该杂志讨论了与这些疾病治疗相关的主要问题，包括主要药物类别的药理学、疗效和不良反应；关于新开发药物和药物类别的信息；心血管疾病病因的最新研究的治疗意义；以及特定临床情况的实际管理。美国心血管药物杂志提供了一系列增强功能，旨在提高期刊内容的可见性、读者群和教育价值。每篇文章都附有要点总结，为广泛的读者提供内容的高效概述。文章可能还附有通俗易懂的摘要，以帮助患者、护理人员和他人理解重要的医学进展。该杂志还提供包括幻灯片集、视频和动画在内的其他增强功能的选项。所有增强功能都经过与文章本身相同的高标准同行评审。同行评审使用Editorial Manager®进行，并支持一个国际专家数据库。该数据库与其他Adis期刊共享。